Factors associated with depression in cancer patients during chemotherapy

Keywords: Neoplasms; Depression; Drug Therapy; Oncology Nursing.

Abstract

Objective: to analyze the factors associated with depression in cancer patients during chemotherapy. Methods: a descriptive cross-sectional study of 208 patients undergoing chemotherapy. A general characterization questionnaire and the Beck Depression Inventory were used. Results: most were women, between 40 and 79 years old, married, Catholic, retired/housewives, with elementary school and had no depression (71.2%), while 17.3% had depression and 11.5% dysphoria. In the associations, it was found statistical significance in the associations of the Beck Depression Inventory with surgery (p=0.002), time since surgery (p=0.014), time since chemotherapy onset (p=0.030), and side effects of chemotherapy (p=0.019). Conclusion: there was a low incidence of depression, but the frequency was higher in patients who did not undergo concomitant surgery, who had started chemotherapy for up to six months and who reported more side effects during treatment.

References

World Health Organization. International Agency for Research on Cancer. Globocan 2018 [Internet]. 2018 [cited July 15, 2019]. Available from: http://globocan.iarc.fr/tomorrow/home

Ministério da Saúde (BR). Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA). Coordenação de Prevenção e Vigilância. Estimativa 2018: incidência de câncer no Brasil [Internet]. 2017 [citado 2019 Jul 15]. Disponível em: https://www.inca.gov.br/publicacoes/livros/estimativa-2018-incidencia-de-cancer-no-brasil

Separovic R, Silovski T, Vuger AT, Bajic Z, Silovski H, Juric A. Association of breast cancer symptoms with patients’ quality of life and depression; a Croatian cross-sectional study. Psychiatr Danub [Internet]. 2019 [cited July 23, 2019]; 31(Suppl. 1):92-8. Available from: http://www.psychiatria-danubina.com/UserDocsImages/pdf/dnb_vol31_sup1/dnb_vol31_sup1_92.pdf

Hovaldt HB, Andersen I, Sandager M, Sperling C, Frederiksen K, Bidstrup PE, et al. The role of social position and anxiety and depressive symptoms among Danish cancer survivors. Acta Oncol. 2015; 54(5):693-703. doi: https://doi.org/10.3109/0284186X.2014.996666

Miranda SL, Lanna MAL, Felippe WC. Espiritua- lidade, depressão e qualidade de vida no enfrentamento do câncer: estudo exploratório. Psicol Cienc Prof. 2015; 35(3):870-85. doi: http://dx.doi.org/10.1590/1982-3703002342013

Chang CH, Chen SJ, Liu CY. Adjuvant treatments of breast cancer increase the risk of depressive disorders: a population-based study. J Affect Disorders. 2015; 182:44-9. doi: https://doi.org/10.1016/j.jad.2015.04.027

Tung HY, Chao TB, Lin YH, Wu SF, Lee HY, Ching CY, et al. Depression, fatigue, and QoL in colorectal cancer patients during and after treatment. West J Nurs Res. 2016; 38(7):893-908. http://dx.doi.org/10.1177/0193945916630256

Boing L, Pereira GS, Araújo CCR, Sperandio FF, Loch MSG, Bergmann A, et al. Factors associated with depression symptoms in women after breast cancer. Rev Saúde Pública. 2019; 53:30. doi: https://doi.org/10.11606/S1518-8787.2019053000786

Santos CA, Ribeiro AQ, Rosa COB, Ribeiro RCL. Depressão, déficit cognitivo e fatores associados à desnutrição em idosos com câncer. Cienc Saúde Coletiva. 2015; 20(3):751-60. doi: http://dx.doi.org/10.1590/1413-81232015203.06252014

Hamish RS. Depression in cancer patients: pathogenesis, implications and treatment. Oncol Lett. 2015; 9(4):1509-14. doi: http://dx.doi.org/10.3892/ol.2015.2944

Polit DF, Beck CT. Fundamentos de pesquisa em enfermagem: avaliação de evidências para a prática da enfermagem. Porto Alegre: Artmed; 2019.

Gorestein C, Andrade L. Inventário de depressão de Beck: propriedades psicométricas da versão em português. Rev Psiquiatr Clin [Internet]. 1998 [citado 2019 Jul 15]; 25(5):245-50. Disponível em:https://www.researchgate.net/publication/284700806_Inventario_de_depressao_de_Beck_Propriedades_psicometricas_da_versao_em_portugues

Gomes-Oliveira MH, Gorestein C, Lotufo Neto F, Andrade LH, Wang YP. Validation of the Brazilian Portuguese version of the Beck Depression Inventory-II in a community sample. Rev Bras Psiquiatr. 2012; 34(4):389-94. doi: http://dx.doi.org/10.1016/j.rbp.2012.03.005

Lima MP, Oliveira DS, Irigaray TQ. Symptoms of depression and anxiety in cancer outpatients: predictive variables. Psicooncol. 2018; 15(2):373-84. doi: http://dx.doi.org/10.5209/PSIC.61443

Li Q, Lin Y, Xu Y, Zhou H. The impact of depression and anxiety on quality of life in Chinese cancer patient-family caregiver dyads, a cross-sectional study. Health Qual Life Outcomes. 2018; 16(1):230. doi: https://doi.org/10.1186/s12955-018-1051-3

Kaminska M, Kubiatowski T, Ciszewski T, Czarnocki KJ, Makara-Studzinska M, Bojar I, et al. Evolution of symptoms of anxiety and depression in women with breast cancer after breast amputation or conservation treated with adjuvant chemotherapy. Ann Agric Environ Med. 2015; 22(1):185-9. doi: https://doi.org/10.5604/12321966.1141392

Ho SY, Rohan KJ, Parent J, Tager FA, McKinley PS. A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer. J Pain Symptom Manage. 2015; 49(4):707-15. doi: http://dx.doi.org/10.1016/j.jpainsymman.2014.09.009

Bergerot CD, Mitchell HR, Ashing KT, Kim Y. A prospective study of changes in anxiety, depression, and problems in living during chemotherapy treatments: effects of age and gender. Support Care Cancer. 2017; 25(6):1897-904. doi: https://doi.org/10.1007/s00520-017-3596-9

Inhestern L, Beierlein V, Bultmann JC, Möller B, Romer G, Koch U, et al. Anxiety and depression in working-age cancer survivors: a register-based study. BMC Cancer. 2017; 17(1):347. doi: https://doi.org/10.1186/s12885-017-3347-9

Huang Z, Zhao J, Ding K, Lv Y, Zhang C, Chao H, et al. Depression involved in self-reported prospective memory problems in survivors of breast cancer who have received chemotherapy. Medicine. 2019; 98(16):e15301. doi: https://doi.org/10.1097/MD.0000000000015301

Published
2019-10-22
Section
Research Article